Alcista
$27.83
Precio del escenario
$28.990
-0.531 (-1.83%)Al cierre
Helen of Troy Limited is a global consumer products company. The Company has two operating business segments, namely Beauty & Wellness and Home & Outdoor. The Beauty & Wellness segment includes beauty products such as hairstyling appliances, grooming tools, liquid and aerosol personal care items, and nail care products. It also includes wellness devices such as humidifiers, thermometers, water and air purifiers, heaters, and fans. The Home & Outdoor segment includes consumer products for home-related activities such as food preparation and storage, cooking, cleaning, organization, and beverage service. It also includes products for outdoor and mobile use, such as hydration containers, coolers, food storage items, backpacks, and travel gear. The Company offers products through a portfolio of brands, including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Olive & June.
Helen of Troy Ltd (HELE) is currently priced at $26.51, which is slightly below the average analyst price target of $28.67. The stock has shown a year-to-date increase of 28.63%, indicating strong performance, but the recent RSI of 45.468 suggests it is nearing oversold conditions. The forward P/E ratio of 8.4674 indicates potential for growth, yet the company has faced significant net losses in recent quarters, with a net income of -450.72 million in Q1 2026. Therefore, while there are positive catalysts such as improved profitability and a positive cash flow outlook, the risks associated with recent losses and a declining gross margin (44.61% in Q4 2026) suggest a cautious approach. Investors should consider holding their positions until clearer signs of recovery emerge.
UBS
$29
2026-10-09
UBS
2026-10-09
Precio objetivo
$29
Canaccord
$26
2026-10-06
Canaccord
2026-10-06
Precio objetivo
$26
UBS
$28
2026-07-09
UBS
2026-07-09
Precio objetivo
$28
Canaccord
$25
2026-07-09
Canaccord
2026-07-09
Precio objetivo
$25
UBS
$25
2026-04-24
UBS
2026-04-24
Precio objetivo
$25
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Helen of Troy Q2 Earnings Beat Expectations, Raises FY27 Outlook

Helen of Troy Q2 Earnings Beat Expectations Significantly

Helen of Troy Reports Strong Q2 Results with Improved Profitability

Helen of Troy to Release Q2 FY2027 Results on October 8, 2026

Hydro Flask and Role Model Launch Limited Edition Drinkware Collection
Helen of Troy Limited is a global consumer products company. The Company has two operating business segments, namely Beauty & Wellness and Home & Outdoor. The Beauty & Wellness segment includes beauty products such as hairstyling appliances, grooming tools, liquid and aerosol personal care items, and nail care products. It also includes wellness devices such as humidifiers, thermometers, water and air purifiers, heaters, and fans. The Home & Outdoor segment includes consumer products for home-related activities such as food preparation and storage, cooking, cleaning, organization, and beverage service. It also includes products for outdoor and mobile use, such as hydration containers, coolers, food storage items, backpacks, and travel gear. The Company offers products through a portfolio of brands, including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Olive & June. It operates in the Consumer Cyclicals sector (ELECTRIC HOUSEWARES & FANS industry).
Helen of Troy Ltd (HELE) is currently priced at $26.51, which is slightly below the average analyst price target of $28.67. The stock has shown a year-to-date increase of 28.63%, indicating strong performance, but the recent RSI of 45.468 suggests it is nearing oversold conditions. The forward P/E ratio of 8.4674 indicates potential for growth, yet the company has faced significant net losses in recent quarters, with a net income of -450.72 million in Q1 2026. Therefore, while there are positive catalysts such as improved profitability and a positive cash flow outlook, the risks associated with recent losses and a declining gross margin (44.61% in Q4 2026) suggest a cautious approach. Investors should consider holding their positions until clearer signs of recovery emerge.
5 analysts cover HELE: 3 rate it Buy, 1 Hold and 1 Sell. The average price target is 22.00.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.